Science Explorer Interactive view Map
Company · Malvern · United States

VenatoRx Pharmaceuticals (United States)

venatorx.comROR OpenAlex
Research works
36
▲ 211% vs 2013–17
Citations
832
23.0 per fractional work
Top-10% rate
17.6%
record average 16.5%
Open access
76%
world 28%

Not ranked overall: VenatoRx Pharmaceuticals (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.67× its world share, 0 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 6.97× its world share, 6 worksBiochemistry, Geneti…Immunology and Microbiology: 9.04× its world share, 2 worksImmunology and Micro…Chemistry: 1.89× its world share, 0 worksChemistryEnvironmental Science: 0.58× its world share, 0 worksEnvironmental ScienceMaterials Science: 0.24× its world share, 0 worksMaterials ScienceMedicine: 2.28× its world share, 8 worksMedicine1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 9.0×. Every wedge is a field page.

Which keywords describe research at VenatoRx Pharmaceuticals (United States)?

By fractional works in all years, weighted toward what it does more of than the world: Antibiotic Resistance, Antimicrobial Resistance, ESKAPE Pathogens, Multidrug-Resistant Bacteria, Antibiotic Pharmacokinetics, Critically Ill Patients, Epidemiology and Drug Resistance.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 29 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 29 words, with their numbers
  1. Antibiotic Resistance10▲ 66×7 topics
  2. Antimicrobial Resistance6▲ 69×3 topics
  3. ESKAPE Pathogens6▲ 319×1 topic
  4. Multidrug-Resistant Bacteria6▲ 319×1 topic
  5. Epidemiology5▲ 3.6×12 topics
  6. Antibiotic Pharmacokinetics5▲ 308×1 topic
  7. Critically Ill Patients5▲ 308×1 topic
  8. Drug Resistance3▲ 25×4 topics
  9. Infectious Diseases2▲ 27×2 topics
  10. Public Health2▲ 4.7×2 topics
  11. Antimicrobial Stewardship2▲ 207×1 topic
  12. Global Health2▲ 47×1 topic
  13. Neurotransmission2▲ 45×1 topic
  14. Synaptic Plasticity2▲ 19×1 topic
  15. Immune Response2▲ 7.4×4 topics
  16. Microbial Communities2▲ 12×2 topics
  17. Environmental Impact1▲ 3.0×2 topics
  18. Antibiotics1▲ 47×1 topic
  19. Antiviral Therapy1▲ 24×2 topics
  20. Crystal Structure1▲ 14×2 topics
  21. Drug Discovery1▲ 9.0×3 topics
  22. Genomics1▲ 9.9×4 topics
  23. Liver Disease1▲ 27×2 topics
  24. Resistance Genes1▲ 96×1 topic
  25. Signal Transduction1▲ 14×2 topics
  26. Cell Signaling1▲ 8.7×2 topics
  27. Treatment1▲ 2.4×5 topics
  28. Hepatocellular Carcinoma1▲ 13×2 topics
  29. Inflammation1▲ 1.21×7 topics

Which research topics does VenatoRx Pharmaceuticals (United States) publish most on?

By volume in 2022–2025: Antibiotic Resistance in Bacteria, Antibiotics Pharmacokinetics and Efficacy, Antibiotic Use and Resistance and Urinary Tract Infections Management.

Antibiotic Resistance in…4Antibiotic Resistance in Bacteria: 4 fractional worksAntibiotics Pharmacokine…4Antibiotics Pharmacokinetics and Efficacy: 4 fractional worksAntibiotic Use and Resistance: 1 fractional worksUrinary Tract Infections Management: 1 fractional worksPlant Pathogenic Bacteria Studies: 0 fractional worksPharmaceutical and Antibiotic Environmental Impacts: 0 fractional worksBacterial Genetics and Biotechnology: 0 fractional worksInfections and bacterial resistance: 0 fractional worksPneumonia and Respiratory Infections: 0 fractional worksBiosimilars and Bioanalytical Methods: 0 fractional works
Molecular MedicinePharmacologyApplied Microbiology and BiotechnologyEpidemiology5 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Antibiotic Resistance in Bacteria Molecular Medicine 4 works
  2. 2 Antibiotics Pharmacokinetics and Efficacy Pharmacology 4 works
  3. 3 Antibiotic Use and Resistance Applied Microbiology and Biotechnology 1 works
  4. 4 Urinary Tract Infections Management Epidemiology 1 works
  5. 5 Plant Pathogenic Bacteria Studies Plant Science 0 works
  6. 6 Pharmaceutical and Antibiotic Environmental Impacts Pollution 0 works
  7. 7 Bacterial Genetics and Biotechnology Genetics 0 works
  8. 8 Infections and bacterial resistance Endocrinology 0 works
  9. 9 Pneumonia and Respiratory Infections Epidemiology 0 works
  10. 10 Biosimilars and Bioanalytical Methods Immunology 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available76.1%not open23.9%

World: 28% of research is openly available.

with international co-authors21.7%domestic only78.3%

World: 19% is written across borders.

How has VenatoRx Pharmaceuticals (United States)'s research output changed?

Output in 2018–2022 was 211% higher than in 2013–2017.

199520002005201020152020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Malvern

All research institutions in Malvern

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.